Variant position: 8 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 161 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Mouse MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Pig MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Bovine MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Rabbit MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Chicken MDDIYKA AVEQLTEEQKNEFKAAFDIFV
Drosophila ------- MSDELTKEQTALLRNAFNAFD
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 161 Troponin C, slow skeletal and cardiac muscles
1 – 1 N-acetylmethionine
3 – 9
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
Landstrom A.P.; Parvatiyar M.S.; Pinto J.R.; Marquardt M.L.; Bos J.M.; Tester D.J.; Ommen S.R.; Potter J.D.; Ackerman M.J.;
J. Mol. Cell. Cardiol. 45:281-288(2008)
Cited for: VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145; CHARACTERIZATION OF VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145;
A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy.
Pinto J.R.; Parvatiyar M.S.; Jones M.A.; Liang J.; Ackerman M.J.; Potter J.D.;
J. Biol. Chem. 284:19090-19100(2009)
Cited for: CHARACTERIZATION OF VARIANTS CMH13 VAL-8; TYR-84; ASP-134 AND GLU-145;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.